Back to Search
Start Over
Crucell and GeneMax Enter PER.C6(TM) License Agreement in Gene Delivery Field to Advance Clinical Trial
- Source :
- Europe Intelligence Wire. August 12, 2003
- Publication Year :
- 2003
-
Abstract
- (From Hugin) Leiden, The Netherlands, August 12, 2003 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) and US-based GeneMax Corp. (OTC Bulletin Board: GMXX; Frankfurt: GX1) today announced that [...]
- Subjects :
- Crucell N.V.
GeneMax Corp
Immunopharmacology
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Europe Intelligence Wire
- Publication Type :
- News
- Accession number :
- edsgcl.106544575